ABL DIAGNOSTICS (ABLD.PA) Fundamental Analysis & Valuation

EPA:ABLD • FR001400AHX6

Current stock price

3.54 EUR
+0.32 (+9.94%)
Last:

This ABLD.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ABLD.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ABLD was profitable.
  • ABLD had positive earnings in 4 of the past 5 years.
  • In the past 5 years ABLD reported 4 times negative operating cash flow.
ABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

  • The Return On Assets of ABLD (4.17%) is comparable to the rest of the industry.
  • ABLD's Return On Equity of 6.69% is in line compared to the rest of the industry. ABLD outperforms 43.75% of its industry peers.
Industry RankSector Rank
ROA 4.17%
ROE 6.69%
ROIC N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ABLD.PA Yearly ROA, ROE, ROICABLD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • ABLD's Profit Margin of 8.51% is amongst the best of the industry. ABLD outperforms 81.25% of its industry peers.
  • The Operating Margin and Gross Margin are not available for ABLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 8.51%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABLD.PA Yearly Profit, Operating, Gross MarginsABLD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400

6

2. ABLD.PA Health Analysis

2.1 Basic Checks

  • ABLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ABLD remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for ABLD has been increased compared to 5 years ago.
  • ABLD has a better debt/assets ratio than last year.
ABLD.PA Yearly Shares OutstandingABLD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ABLD.PA Yearly Total Debt VS Total AssetsABLD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • ABLD has an Altman-Z score of 9.36. This indicates that ABLD is financially healthy and has little risk of bankruptcy at the moment.
  • ABLD has a better Altman-Z score (9.36) than 93.75% of its industry peers.
  • A Debt/Equity ratio of 0.26 indicates that ABLD is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.26, ABLD is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 9.36
ROIC/WACCN/A
WACC7.94%
ABLD.PA Yearly LT Debt VS Equity VS FCFABLD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

  • ABLD has a Current Ratio of 3.26. This indicates that ABLD is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 3.26, ABLD is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • A Quick Ratio of 2.91 indicates that ABLD has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.91, ABLD belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.26
Quick Ratio 2.91
ABLD.PA Yearly Current Assets VS Current LiabilitesABLD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

5

3. ABLD.PA Growth Analysis

3.1 Past

  • ABLD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 317.39%, which is quite impressive.
  • ABLD shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -48.36% yearly.
  • Looking at the last year, ABLD shows a decrease in Revenue. The Revenue has decreased by -7.68% in the last year.
EPS 1Y (TTM)317.39%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%160.87%
Revenue 1Y (TTM)-7.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.32%

3.2 Future

  • Based on estimates for the next years, ABLD will show a very strong growth in Earnings Per Share. The EPS will grow by 58.74% on average per year.
  • The Revenue is expected to grow by 33.13% on average over the next years. This is a very strong growth
EPS Next Y66.67%
EPS Next 2Y41.42%
EPS Next 3Y58.74%
EPS Next 5YN/A
Revenue Next Year17.2%
Revenue Next 2Y29.55%
Revenue Next 3Y33.13%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABLD.PA Yearly Revenue VS EstimatesABLD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2022 2023 2024 2025 2026 2027 5M 10M 15M
ABLD.PA Yearly EPS VS EstimatesABLD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.02 0.04 0.06 0.08 0.1

1

4. ABLD.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ABLD is valuated quite expensively with a Price/Earnings ratio of 118.00.
  • 75.00% of the companies in the same industry are cheaper than ABLD, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ABLD to the average of the S&P500 Index (25.79), we can say ABLD is valued expensively.
  • ABLD is valuated quite expensively with a Price/Forward Earnings ratio of 57.84.
  • ABLD's Price/Forward Earnings ratio is rather expensive when compared to the industry. ABLD is more expensive than 81.25% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.80. ABLD is valued rather expensively when compared to this.
Industry RankSector Rank
PE 118
Fwd PE 57.84
ABLD.PA Price Earnings VS Forward Price EarningsABLD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABLD.PA Per share dataABLD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ABLD's earnings are expected to grow with 58.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.77
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y58.74%

1

5. ABLD.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.49%, ABLD has a reasonable but not impressive dividend return.
  • ABLD's Dividend Yield is slightly below the industry average, which is at 1.81.
  • ABLD's Dividend Yield is slightly below the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.49%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABLD.PA Yearly Dividends per shareABLD.PA Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04

5.3 Sustainability

DPN/A
EPS Next 2Y41.42%
EPS Next 3Y58.74%
ABLD.PA Yearly Income VS Free CF VS DividendABLD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

ABLD.PA Fundamentals: All Metrics, Ratios and Statistics

ABL DIAGNOSTICS

EPA:ABLD (3/18/2026, 7:00:00 PM)

3.54

+0.32 (+9.94%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.24%
Ins Owner ChangeN/A
Market Cap57.03M
Revenue(TTM)5.45M
Net Income(TTM)463.40K
Analysts82.86
Price Target8.54 (141.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.49%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)35.88%
PT rev (3m)35.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.67%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-12.78%
Revenue NY rev (3m)-12.78%
Valuation
Industry RankSector Rank
PE 118
Fwd PE 57.84
P/S 10.47
P/FCF N/A
P/OCF N/A
P/B 8.23
P/tB 13.67
EV/EBITDA N/A
EPS(TTM)0.03
EY0.85%
EPS(NY)0.06
Fwd EY1.73%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.34
BVpS0.43
TBVpS0.26
PEG (NY)1.77
PEG (5Y)N/A
Graham Number0.54
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 6.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 8.51%
GM N/A
FCFM N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.26
Quick Ratio 2.91
Altman-Z 9.36
F-ScoreN/A
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)317.39%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%160.87%
EPS Next Y66.67%
EPS Next 2Y41.42%
EPS Next 3Y58.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.32%
Revenue Next Year17.2%
Revenue Next 2Y29.55%
Revenue Next 3Y33.13%
Revenue Next 5YN/A
EBIT growth 1Y52.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year278.5%
EBIT Next 3Y133.61%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ABL DIAGNOSTICS / ABLD.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ABL DIAGNOSTICS (ABLD.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ABLD.PA.


What is the valuation status of ABL DIAGNOSTICS (ABLD.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to ABL DIAGNOSTICS (ABLD.PA). This can be considered as Overvalued.


Can you provide the profitability details for ABL DIAGNOSTICS?

ABL DIAGNOSTICS (ABLD.PA) has a profitability rating of 2 / 10.


How financially healthy is ABL DIAGNOSTICS?

The financial health rating of ABL DIAGNOSTICS (ABLD.PA) is 6 / 10.